Amit Rakhit, Md, Mba: Measuring Improvement In Fragile X Syndrome, Other Rare Conditions

Amit Rakhit, MD, MBA: Measuring Improvement in Fragile X Syndrome, Other Rare Conditions

Amit Rakhit, MD, MBA: Developing Therapies for Fragile X Syndrome

Amit Rakhit, MD: Ovid Therapeutics' Approach

Advances in Targeted Treatments in Fragile X Syndrome and Autism

University of California Television (UCTV)

2019 FAST Summit on Angelman Syndrome - OV101 for the Treatment of AS, Dr. Amit Rhakit, Ovid

FAST

Angelman Syndrome Clinical Study Showing Promise

In the clinic: Ovid Therapeutics-OV101 and the engagement with the Angelman community

FAST

Targeting Mitochondria in Human Fragile X Syndrome Neurons

FRAXA Research Foundation

Fragile X study on the Maestro multiwell MEA system: Coffee Break Webinar

Axion BioSystems

Dr. Craig Erickson Speaks About Gene Therapy Translational Studies for Fragile X

FRAXA Research Foundation

Genetics & Diagnosis of Fragile X Syndrome

Fragile X Society, UK

Mutations in MDS - Prognostic and Therapeutic Implications

Inside a Dopamine-Restoring Cell Therapy for PD with BlueRock Therapeutics' Dr. Amit Rakhit

Life Science Connect

Measuring change in treatment studies: Outcome measures for Fragile X syndrome and Down syndrome

UC Davis MIND Institute

How Personalized Medicine May Save Years, Lives

FRAXA Research Foundation

Medication for Individuals with Fragile X Syndrome

National Fragile X Foundation

Multi-Disciplinary Approach to Managing Hypophosphatasia

Rare Disease Report

Fragile X Syndrome - Inheritance (2 of 9)

DNA Learning Center

Medication for Individuals with Fragile X Syndrome (11-2-2017)

National Fragile X Foundation